XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Jun. 30, 2019
Dec. 31, 2018
ASSETS    
Cash and cash equivalents $ 216,411 $ 259,701
Grant funds and other receivables 64,246 121,814
Prepaid expenses and other current assets 39,139 238,189
Total current assets 319,796 619,704
Property and equipment, net (Note 5) 11,827 11,350
Deposits 11,010 11,010
Total assets 342,633 642,064
Current liabilities:    
Accounts payable 116,207 125,859
Accrued expenses (Note 6) 1,510,268 1,238,552
Current portion of notes payable (Note 7) 12,500 260,420
Total current liabilities 1,638,975 1,624,831
Note payable, net of current portion (Note 7) 32,291 39,580
Total liabilities 1,671,266 1,664,411
Commitments (Note 8)
Stockholders’ equity (deficiency):    
Preferred Stock, $.01 par value: Authorized shares – 10,000,000 Issued and outstanding shares – 3,402 and 3,450 at June 30, 2019 and December 31, 2018, respectively (Note 9) 2,337,867 1,971,333
Common stock, $.001 par value: Authorized shares – 600,000,000 Issued and outstanding shares – 813,916 and 437,807 at June 30, 2019 and December 31, 2018, respectively 814 438
Additional paid-in capital 38,165,172 37,482,766
Accumulated deficit (41,832,486) (40,476,884)
Total stockholders’ equity (deficiency) (1,328,633) (1,022,347)
Total liabilities and stockholders’ equity (deficiency) $ 342,633 $ 642,064